Precise methods for shredding or repairing and replacing specific cancer-causing proteins in a malignant cell, developed at ...

Vitamin B12 is long understood as a vital nutrient required for red blood cell formation and nerve function, but a new ...

A human study reveals how naturally occurring fat-derived molecules help switch off inflammation. Researchers at (UCL) have identified an important biological process that helps the body bring ...

In a study published in Cell Research, researchers have identified a fibrous-layer resident subpopulation of P-SSCs labeled ...

Severe skeletal muscle injury, especially volumetric muscle loss, remains difficult to treat because effective regeneration ...

CATL is already dominating the global electric vehicle battery market, but now the company is saying sodium-ion batteries will be widely available by the end of 2026. When is CATL launching sodium-ion ...

Kyushu University scientists have achieved a major leap in fuel cell technology by enabling efficient proton transport at just 300°C. Their scandium-doped oxide materials create a wide, soft pathway ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based ...

A Swedish government agency is investing SEK 130 million ($13.8 million) in the next-generation indoor solar cell technology belonging to Exeger. The company’s Powerfoyle solar cells are an evolution ...

Hyroad Energy bought Nikola's inventory and the intellectual property, though initially the trucking-as-a-service provider was only looking to buy the inventory, Hydrogen fuel cell electric truck ...

The company announced on Monday that it will offer the technology beginning Nov. 24 to all its customers in Ukraine. The company said it had been testing the technology for over a year. Kyivstar users ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while strengthening its prostate cancer franchise built on Erleada. At the center of the ...